Dr. Wolfgang M. Baiker

President and CEO Boehringer Ingelheim USA Corp.

Wolfgang BakerDr Wolfgang M. Baiker studied medicine in Bochum, Berlin, Ulm, Munich and Sheffield (UK), and gained his executive MBA at Pace University (New York). 

Dr Baiker started his career in the Pharmaceutical Industry in 1989 in Clinical Development at Dr. Karl Thomae GmbH, an affiliated company of Boehringer Ingelheim. From 1991 to 1993 he gained experience in US clinical research at Boehringer Ingelheim Pharmaceuticals in Ridgefield, CT.

Between 1994 and 1998 Dr Baiker established International Project Management at Boehringer Ingelheim in the US. From 1998 to 2004 he was responsible for International Project Management at the Corporate Headquarters of Boehringer Ingelheim.

Having lead Development at Boehringer Ingelheim’s largest development site in Biberach, Germany, since 2004, Dr Wolfgang Baiker was in addition responsible for global Development at Boehringer Ingelheim with sites in Germany, USA and Japan from January 2010 until May 2013.

In June 2013 Dr. Baiker joined Boehringer Ingelheim’s Board of Managing Directors with responsibility for Biopharmaceuticals and Operations.  

From July 2016 to February 2018 Dr Baiker was a Member of the Human Pharma Executive Committee with responsibility for Human Pharma Supply and Global Quality.  In addition, Dr Baiker was the Head of the Biopharma Business Unit.

As of March 2018 Dr Baiker assumed the role of US Country Managing Director and President & CEO for BI USA.